1800 202 8726
Understanding your pathology bill

How Much Does an — IHC Panel Cost?

The IHC panel is often the largest item on a cancer pathology bill — bigger than the biopsy that provided the tissue. Understanding what you are being charged for, and why, can help you plan.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • Billed per marker — Each antibody test is a separate charge. A panel of eight markers means eight line items on your bill.
  • The panel size is not arbitrary — Your pathologist decides how many markers to run based on what the initial stain shows. More ambiguous cases need more markers.
  • NABL accreditation matters — An unaccredited laboratory's report may not be accepted by your treating hospital or insurer.
  • Most insurers cover it — IHC is generally covered under health insurance when ordered by an oncologist, but pre-authorisation rules vary by policy.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

An IHC panel in India typically costs more than the biopsy used to obtain the tissue. Each marker is billed separately, and panels running multiple markers at once are common for most diagnoses. Costs vary by laboratory accreditation and city. Most health insurance policies cover IHC when ordered by your treating oncologist.

Why does an IHC panel cost more than the biopsy?

The biopsy is a single procedure. An IHC panel is a series of separate chemical tests, each using a different antibody reagent, each run individually on a slice of your tissue block.

A panel of eight markers means eight separate tests. Each one has a reagent cost, a laboratory processing cost, and a pathologist reading and reporting cost. Those add up.

The number of markers your pathologist orders is not padding. It is determined by what the initial haematoxylin and eosin stain shows and how many possibilities need to be ruled out before a definitive diagnosis can be made.

Terms you will see on your IHC bill

IHC (immunohistochemistry)
A method of staining tissue with antibodies to detect specific proteins. Each protein tested is one marker, one charge.
Panel
A set of markers run together because the pathologist needs all of them to reach a diagnosis. The size of the panel is not fixed — it depends on the clinical question.
Block
The small wax cube that contains your biopsy tissue. Multiple IHC slides can be cut from a single block. If tissue runs out, a repeat biopsy may be needed.
NABL accreditation
National Accreditation Board for Testing and Calibration Laboratories. NABL accreditation means the laboratory meets verified quality standards. Some hospitals and insurers accept reports only from NABL-accredited laboratories.
H&E stain
Haematoxylin and eosin — the routine stain done first on every biopsy. IHC is done after this, when the H&E alone cannot confirm the diagnosis.
Run
Laboratories batch IHC tests and process them together. This is why results may take a day or two even after the tissue has arrived.

Does health insurance cover IHC testing?

Most Indian health insurance policies cover IHC testing when it is ordered by a treating oncologist as part of diagnosis or treatment planning. It falls under diagnostic investigations.

Pre-authorisation requirements vary by policy. Some insurers require approval before the test is run; others settle the bill at discharge without a separate step. Check your policy or call your insurer before the test if cost is a concern.

Government schemes including PM-JAY cover IHC under their diagnostic provisions for enrolled patients. Your treating hospital's patient services team can confirm what is included under your specific enrolment.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

How does cost and quality vary by laboratory type?

Government or trust hospital labPrivate NABL-accredited labSpecialist molecular pathology lab
Indicative cost levelLowerModerate to higherHigher
NABL accreditationOften yesYesYes
Turnaround time2–5 working days (typical)1–3 working days (typical)1–3 working days (typical)
Report acceptanceWidely acceptedWidely acceptedWidely accepted
Insurance billingUsually direct billingUsually direct billingVaries — check before booking
Best suited forCost-sensitive patients with timeMost patients — balance of cost and speedComplex or rare cases needing specialist reading

Common billing questions about IHC

Why does my bill show eight separate charges for one IHC report?

Because each marker is an individual test. When a pathologist orders a panel of eight markers, the laboratory runs eight separate staining procedures, each using a different antibody, each requiring its own reagent and its own reading by the pathologist. Bundling them into one charge is unusual; most laboratories bill per marker, which is why a single IHC report produces multiple line items on the bill.

Can I ask my pathologist to run fewer markers to reduce the cost?

You can ask, but the pathologist is unlikely to reduce the panel without a clinical reason, and for good reason. Markers are ordered because each one narrows a diagnostic possibility. Running fewer than needed risks an incomplete or incorrect diagnosis, which may mean repeating the test later — at additional cost and with further delay to treatment. If cost is a concern, discuss it with your treating oncologist rather than the laboratory, so the clinical implications are part of the conversation.

My insurer denied the IHC claim. What should I do?

Ask your treating oncologist to write a letter explaining why IHC was clinically necessary. Most insurers that deny IHC on first submission accept it on appeal when supported by clinical justification. Also check whether the laboratory is on your insurer's empanelled list — a non-empanelled laboratory may lead to lower reimbursement even if the test itself is covered. Your hospital's billing or insurance liaison team can often help navigate the appeal.

Is it safe to send my tissue block to a laboratory in another city?

Yes, and it is sometimes necessary. Tissue blocks are routinely couriered between cities in India, particularly for specialist second opinions or tests that local laboratories are not equipped to run. The block is irreplaceable, so it should be sent by a reputable courier with tracking, and you should keep a written record of where the block is at all times. Ask the laboratory to return it after testing.

Did you know?

In India, the cost of an IHC panel routinely exceeds the cost of the biopsy procedure that obtained the tissue.

This surprises many families who expected the procedure to be the largest charge. The markers — not the needle — are where the diagnostic expense sits.

Source: Indian Council of Medical Research (ICMR)

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

How much does a single IHC marker cost?

The cost of a single IHC marker in India varies by laboratory type and city. Government and trust hospital laboratories typically charge less than private laboratories. NABL-accredited private laboratories generally charge more, reflecting the quality controls they must maintain. Because these costs change and vary significantly by location, ask the specific laboratory for their current schedule before committing. Your hospital's billing team can usually provide this.

How much does a full IHC panel cost?

A panel cost is the sum of each marker's individual charge. Because the number of markers varies by case — from two or three for a straightforward diagnosis to twelve or more for a complex one — there is no single panel price. Ask your pathologist how many markers are expected, then ask the laboratory for their per-marker rate to estimate the total. Costs listed by laboratories are typically per marker, not per panel.

Why does my bill look so much larger than I expected?

The single most common reason is the IHC panel. Families often budget for the biopsy procedure and are surprised to find that the diagnostic testing on the tissue — the IHC markers — exceeds it. This is not an error on the bill. It is the cost structure of molecular pathology. If you are uncertain about any line item, ask the billing desk to explain what each charge corresponds to before paying.

Should I choose a laboratory on price alone?

NABL accreditation matters more than cost when choosing a laboratory for IHC. A report from an unaccredited laboratory may not be accepted by your treating hospital, a second-opinion centre, or your insurer. If the report is rejected, you may have to repeat the test entirely — which costs more in total than choosing an accredited laboratory at the outset. Among NABL-accredited laboratories, price and turnaround time are reasonable factors to compare.

Is IHC covered under PM-JAY or state government health schemes?

IHC is included in the diagnostic provisions of PM-JAY for enrolled patients, though the specific markers covered and the reimbursement rates are defined by the scheme's package list, which is updated periodically. State government health schemes in Telangana and Andhra Pradesh have their own provisions. Confirm coverage with the patient services desk at your treating hospital before the test, as the hospital's empanelment with the scheme determines what can be billed directly.

What should I do if I cannot afford the full IHC panel?

Tell your treating oncologist before the test, not after the bill arrives. Oncologists can sometimes sequence testing — running the most diagnostic markers first and adding others only if the result is inconclusive — which can reduce the cost without compromising the diagnosis. Your hospital's patient services or social work team may also know of trust funds or government schemes that can help with diagnostic costs for patients who cannot meet them out of pocket.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation